Using genetics to understand the role of kidney function in COVID-19: a mendelian randomization study
Related Experiment Video
Updated: Oct 13, 2025

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
Jie V Zhao1, C Mary Schooling2,3
1School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, 1/F, Patrick Manson Building, 7 Sassoon Road, Hong Kong, SAR, China. janezhao@hku.hk.
Insights
Better kidney function, indicated by higher estimated glomerular filtration rate (eGFR), is linked to a reduced risk of severe COVID-19. This suggests kidney function is a potential therapeutic target for COVID-19 treatment.
Area of Science:
- Genetics
- Nephrology
- Infectious Diseases
Background:
- Kidney dysfunction is a known predictor of mortality in severe COVID-19.
- The causal relationship between kidney function and severe COVID-19 has been unclear due to confounding in observational studies.
- Mendelian randomization is employed to investigate the unconfounded role of kidney function in severe COVID-19.
Purpose of the Study:
- To determine if impaired kidney function is a cause or symptom of severe COVID-19.
- To assess the causal effect of genetically predicted kidney function on severe COVID-19 risk.
- To explore the association between kidney function and COVID-19 hospitalization and infection.
Main Methods:
- Utilized genome-wide significant, uncorrelated genetic variants to predict kidney function (eGFR and UACR).
- Employed Mendelian randomization to analyze the association between genetically instrumented kidney function and severe COVID-19.
- Examined large cohorts for severe COVID-19 (8,779 cases, 1,001,875 controls), COVID-19 hospitalization (24,274 cases, 2,061,529 controls), and all COVID-19 (112,612 cases, 2,474,079 controls).
Main Results:
- Genetically predicted higher eGFR was associated with a reduced risk of severe COVID-19 (OR 0.90, 95% CI 0.83-0.98).
- No significant association was found between genetically predicted higher eGFR and COVID-19 hospitalization or infection.
- Genetically predicted lower UACR (better kidney function) showed no significant association with COVID-19 outcomes.
Conclusions:
- Kidney function emerges as a significant factor and potential therapeutic target in severe COVID-19.
- Medications that improve kidney function, such as antihypertensives, may offer benefits for COVID-19 treatment.
- Findings support drug repositioning strategies targeting kidney function for COVID-19 management.
Background:
Kidney dysfunction occurs in severe COVID-19, and is a predictor of COVID-19 mortality. Whether kidney dysfunction causes severe COVID-19, and hence is a target of intervention, or whether it is a symptom, is unclear because conventional observational studies are open to confounding. To obtain unconfounded estimates, we used Mendelian randomization to examine the role of kidney function in severe COVID-19.
Methods:
We used genome-wide significant, uncorrelated genetic variants to predict kidney function, in terms of estimated glomerular filtration rate (eGFR) and urine albumin-to-creatinine ratio (UACR), and then assessed whether people with genetically instrumented higher eGFR or lower UACR, an indication of better kidney function, had a lower risk of severe COVID-19 (8779 cases, 1,001,875 controls), using the largest available cohorts with extensive genotyping. For comprehensiveness, we also examined their role in COVID-19 hospitalization (24,274 cases, 2,061,529 controls) and all COVID-19 (1,12,612 cases, 2,474,079 controls).
Results:
Genetically instrumented higher eGFR was associated with lower risk of severe COVID-19 (odds ratio (OR) 0.90, 95% confidence interval (CI) 0.83, 0.98) but not related to COVID-19 hospitalization or infection. Genetically instrumented UACR was not related to COVID-19.
Conclusions:
Kidney function appears to be one of the key targets for severe COVID-19 treatment. Use of available medications to improve kidney function, such as antihypertensives, might be beneficial for COVID-19 treatment, with relevance to drug repositioning.
Related Concept Videos
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Single Nucleotide Polymorphisms-SNPs
Kidney Transplant I: Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury II: Pathophysiology
Chronic Kidney Disease I: Introduction

